Compare ZG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZG | ALKS |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.7B |
| IPO Year | 2014 | 2012 |
| Metric | ZG | ALKS |
|---|---|---|
| Price | $36.82 | $48.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 14 |
| Target Price | ★ $78.68 | $43.43 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.75 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | $1,076,794,000.00 | ★ $1,475,899,000.00 |
| Revenue This Year | $17.77 | $24.26 |
| Revenue Next Year | $13.31 | $4.47 |
| P/E Ratio | $208.00 | ★ N/A |
| Revenue Growth | ★ 27.19 | N/A |
| 52 Week Low | $29.03 | $25.17 |
| 52 Week High | $90.22 | $55.67 |
| Indicator | ZG | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 57.48 | 43.53 |
| Support Level | $35.11 | $47.66 |
| Resistance Level | $37.59 | $51.25 |
| Average True Range (ATR) | 1.80 | 1.61 |
| MACD | 0.22 | -0.13 |
| Stochastic Oscillator | 79.35 | 6.63 |
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.